Open Orphan proposed distribution in specie - DirectorsTalk Interviews
Open Orphan proposed distribution in specie 7:11 am Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and a world leader in vaccine and antiviral testing using human challenge clinical trials, has announced that, further to previous announcements, it proposes to make a distribution in specie of the entire issued share capital of its wholly-owned subsidiary Orph Pharma IP Company Limited to Poolbeg Pharma Limite...
Source: directorstalkinterviews.com